13.02.2014 • News • Merck • Pharmaceuticals • Reckitt Benckiser

Reckitt Benckiser Says Pharma Review Ongoing

Reckitt Benckiser has said the strategic review of its pharmaceuticals business is still in progress and it will update investors over the course of 2014.

In October 2013, the company said it was considering all options for the business, which could include selling it, spinning it off, or keeping it.

Regarding acquisitions, CEO Rakesh Kapoor said Reckitt would continue to be active in the consumer health space, but declined to comment specifically on reports that consumer companies have approached U.S. drug maker Merck & Co about its consumer business.

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Special Issue

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.